1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Pr Bruno LEVY: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock Levosimendan 2.5 MG/ML Injectable Solution, Placebo - Cardiogenic Shock | Phase 3 | Recruiting | Pr Bruno LEVY | 610 | 2023-07-03 | 2025-08-05 |
Heart Failure (1) · Shock, Cardiogenic (1)
Simendan (1)
France (1)